Rivaroxaban
Indication:
Prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF)
Product Features
- Form:
- Film Coated Tablets
- Active Ingredient:
- Rivaroxaban
- Active Ingredient Amount:
- 20 mg
- Commercial Figure:
In blister packages of 28 film-coated tablets